U.S. Markets closed
  • S&P 500

    3,269.96
    -40.15 (-1.21%)
     
  • Dow 30

    26,501.60
    -157.51 (-0.59%)
     
  • Nasdaq

    10,911.59
    -274.00 (-2.45%)
     
  • Russell 2000

    1,538.48
    -23.10 (-1.48%)
     
  • Crude Oil

    35.72
    -0.45 (-1.24%)
     
  • Gold

    1,878.80
    +10.80 (+0.58%)
     
  • Silver

    23.72
    +0.35 (+1.52%)
     
  • EUR/USD

    1.1650
    -0.0029 (-0.2446%)
     
  • 10-Yr Bond

    0.8600
    +0.0250 (+2.99%)
     
  • Vix

    38.02
    +0.43 (+1.14%)
     
  • GBP/USD

    1.2951
    +0.0028 (+0.2163%)
     
  • USD/JPY

    104.6200
    +0.0100 (+0.0096%)
     
  • BTC-USD

    13,808.61
    +193.99 (+1.42%)
     
  • CMC Crypto 200

    265.42
    +1.78 (+0.68%)
     
  • FTSE 100

    5,577.27
    -4.48 (-0.08%)
     
  • Nikkei 225

    22,977.13
    -354.81 (-1.52%)
     

Veracyte Inc (VCYT) Chairman and CEO Bonnie H Anderson Sold $1.9 million of Shares

GuruFocus.com
·1 min read

- By insider

Chairman and CEO of Veracyte Inc (30-Year Financial, Insider Trades) Bonnie H Anderson (insider trades) sold 50,000 shares of VCYT on 10/08/2020 at an average price of $38 a share. The total sale was $1.9 million.


Veracyte Inc is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The Company's first commercial solution, the Afirma Thyroid FNA Analysis, centers on the proprietary Afirma Gene Expression Classifier. Veracyte Inc has a market cap of $2.38 billion; its shares were traded at around $41.46 with and P/S ratio of 18.20. Veracyte Inc had annual average EBITDA growth of 31.40% over the past five years. GuruFocus has detected 2 severe warning signs with Veracyte Inc. .

CEO Recent Trades:

  • Chairman and CEO Bonnie H Anderson sold 50,000 shares of VCYT stock on 10/08/2020 at the average price of $38. The price of the stock has increased by 9.11% since.

  • Chairman and CEO Bonnie H Anderson sold 20,000 shares of VCYT stock on 09/10/2020 at the average price of $30.89. The price of the stock has increased by 34.22% since.

Directors and Officers Recent Trades:

  • Chief Scientific & Med Officer Giulia C Kennedy sold 2,500 shares of VCYT stock on 10/06/2020 at the average price of $35.21. The price of the stock has increased by 17.75% since.

For the complete insider trading history of VCYT, click here

.This article first appeared on GuruFocus.